MSF warns governments are failing to test, treat and prevent TB in children

November 14, 2023

Governments must immediately implement the latest WHO guidelines to stop children from dying from this deadly yet curable disease Geneva, 14 November 2023 - Médecins Sans Frontières/Doctors Without Borders (MSF)  welcomed the World Health Organization’s (WHO) ‘Roadmap towards ending TB in...

Afghanistan: The MSF hospital in Kandahar provides hope for people with TB

December 8, 2022

Jawahira was referred to the Médecins Sans Frontières (MSF) tuberculosis (TB) hospital in Kandahar earlier this year from a clinic in Daikundi, central Afghanistan. “I used to visit private clinics, but instead of giving me TB medication, they usually just...

Tuberculosis: Promising new tuberculosis drug pretomanid approved, but will it be affordable?

August 15, 2019

GENEVA/NEW YORK – Doctors Without Borders/Médecins Sans Frontières (MSF) welcomes the approval by the US Food and Drug Administration (FDA) of a combination regimen containing a new drug, pretomanid, for the treatment of extensively drug-resistant tuberculosis (XDR-TB). As the third...

Mumbai: A new life with new tuberculosis drugs

December 1, 2016

Increasingly drug-resistant strains of tuberculosis (TB) are on the rise in India, particularly in hotspots such as Mumbai. Two new TB drugs, bedaquiline and delaminid, show promising results and offer renewed hope to patients whose TB strains are resistant to...

India: Renewed hope with new drugs

October 28, 2016

Two new drugs, bedaquiline and delamanid, are proving to be the very last lifeline for tuberculosis (TB) patients with the most extreme forms of drug resistance. While a few patients benefit from these new drugs in India, many die before being able...